Skip to main content
. 2018 Jul 11;37(46):6041–6053. doi: 10.1038/s41388-018-0403-0

Table 1.

Association between MUC20 expression with clinicopathologic characteristics of PDAC

Characteristics MUC20 expression (n a ) P value b
Low High
Age (years) 0.548
 ≤60 7 9
 >60 15 30
Gender 0.173
 Male 17 23
 Female 5 16
Differentiated grades 0.342
 Better 19 29
 Poor 3 10
Lymph node metastasis 0.416
 No 11 14
 Yes 11 25
Distant metastasis 0.588
 No 9 13
 Yes 13 26
AJCC stages 0.251
 Early stagec 10 12
 Late stage 12 27
Local recurrence 0.026*
 No 9 6
 Yes 13 33
Adjuvant therapy 0.426
 No 14 20
 Yes 8 19

anumber of case

bChi-square test

cearly stage indicates AJCC stage IB and IIA; late stage indicates ATCC stage IIB, III, and IV

*P < 0.05